Chang Ho Ahn (안창호)

Dr. Chang Ho Ahn is Chairman of the Council of Entrepreneurial Transformation and Director of the Board of the Global Partners, helping people in the Third World. He is an internationally recognized drug development expert in the fields of cancer and biotechnology. He is the founder and former Chairman and CEO of Rexahn Pharmaceuticals, Inc. Dr. Ahn was a key author of several FDA guidance documents. Before joining the FDA, he carried out cancer research at NIH and at Emory University’s School of Medicine. He served as President of the Society of Biomedical Research and Editor-in-Chief of the Journal of Biomedical Research. He was named one of Maryland’s Top 25 CEOs by the Gazette newspaper in 2006. One of his many inventions, Archexin, has been named one of “100 Great Investigational Drugs” in the world in 2007 by R&D Directions. Dr. Ahn earned his Ph.D. from Ohio State University and B.S. degrees from Creighton University and Seoul National University. medmighty@yahoo.com, https://relationshipscience.com/person/chang-h-ahn-3195544.